Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goepel

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Der Urologe. Ausg. A|May 1, 1991
[TNM-oriented therapy planning in bladder cancer]M Goepel, H Rübben
Der Urologe. Ausg. A|December 14, 2011
[Medicine and economy are not a contradiction]R Tunder, M Goepel
Der Urologe. Ausg. A|April 27, 2004
[The aging bladder]H Palmtag, M Goepel
Der Urologe. Ausg. A|March 23, 2007
[How do medications used to treat urinary incontinence affect the cerebral function of the elderly?]M Goepel, K-C Steinwachs
Der Urologe. Ausg. A|March 16, 2007
[Introduction to the topic: incontinence in the aged--(un)avoidable?]D Schultz-Lampel, M Goepel
European Journal of Pharmacology|April 17, 1998
Differential alpha1-adrenoceptor labeling by [3H]prazosin and [3H]tamsulosinM C Michel, M Goepel
Der Urologe. Ausg. A|August 28, 2003
[The overactive bladder--a case for the urologist]M Goepel, M C Michel
European Urology|December 9, 2000
Treatment satisfaction of patients with lower urinary tract symptoms: randomised controlled trials vs. real life practiceM C Michel, M Goepel
Der Urologe. Ausg. A|June 18, 2011
[Anticholinergic agents for overactive bladder syndrome: current head-to-head comparison]M Goepel, D Schultz-Lampel
European Urology|March 29, 2001
Lower urinary tract symptoms suggestive of benign prostatic obstruction--what's the long-term effectiveness of medical therapies?M C Michel, M Goepel
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Der Urologe. Ausg. A|May 1, 1991
[TNM-oriented therapy planning in bladder cancer]M Goepel, H Rübben
Der Urologe. Ausg. A|December 14, 2011
[Medicine and economy are not a contradiction]R Tunder, M Goepel
Der Urologe. Ausg. A|April 27, 2004
[The aging bladder]H Palmtag, M Goepel
Der Urologe. Ausg. A|March 23, 2007
[How do medications used to treat urinary incontinence affect the cerebral function of the elderly?]M Goepel, K-C Steinwachs
Der Urologe. Ausg. A|March 16, 2007
[Introduction to the topic: incontinence in the aged--(un)avoidable?]D Schultz-Lampel, M Goepel
European Journal of Pharmacology|April 17, 1998
Differential alpha1-adrenoceptor labeling by [3H]prazosin and [3H]tamsulosinM C Michel, M Goepel
Der Urologe. Ausg. A|August 28, 2003
[The overactive bladder--a case for the urologist]M Goepel, M C Michel
European Urology|December 9, 2000
Treatment satisfaction of patients with lower urinary tract symptoms: randomised controlled trials vs. real life practiceM C Michel, M Goepel
Der Urologe. Ausg. A|June 18, 2011
[Anticholinergic agents for overactive bladder syndrome: current head-to-head comparison]M Goepel, D Schultz-Lampel
European Urology|March 29, 2001
Lower urinary tract symptoms suggestive of benign prostatic obstruction--what's the long-term effectiveness of medical therapies?M C Michel, M Goepel
Pageof 11